Roche Holding AG (OTCMKTS:RHHBY) Receives $51.50 Consensus PT from Analysts

Roche Holding AG (OTCMKTS:RHHBY) has received an average rating of “Hold” from the eleven ratings firms that are covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $51.50.

A number of analysts have recently weighed in on the company. TD Cowen reaffirmed a “hold” rating on shares of Roche in a research report on Tuesday, February 10th. Argus raised Roche from a “hold” rating to a “buy” rating in a research note on Monday, April 6th. Wolfe Research restated an “outperform” rating on shares of Roche in a report on Thursday, February 26th. Morgan Stanley raised Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 price target on the stock in a research report on Friday, April 24th. Finally, Citigroup began coverage on Roche in a research report on Tuesday, January 27th. They set a “buy” rating for the company.

Roche Stock Up 1.2%

Roche stock opened at $53.34 on Friday. The company has a current ratio of 1.38, a quick ratio of 1.12 and a debt-to-equity ratio of 0.72. Roche has a 52-week low of $37.51 and a 52-week high of $60.85. The company’s 50 day moving average is $50.50 and its two-hundred day moving average is $51.72.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. McIlrath & Eck LLC purchased a new stake in shares of Roche in the 1st quarter valued at approximately $39,000. Opal Capital LLC purchased a new stake in shares of Roche during the 1st quarter worth $4,448,000. PNC Financial Services Group Inc. grew its stake in shares of Roche by 5.4% during the first quarter. PNC Financial Services Group Inc. now owns 23,456 shares of the company’s stock worth $1,166,000 after purchasing an additional 1,201 shares in the last quarter. S&CO Inc. increased its holdings in Roche by 163.0% in the first quarter. S&CO Inc. now owns 140,551 shares of the company’s stock valued at $6,880,000 after buying an additional 87,107 shares during the last quarter. Finally, Enterprise Financial Services Corp increased its holdings in Roche by 6.6% in the first quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock valued at $277,000 after buying an additional 345 shares during the last quarter.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann?La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.